Physician profile
Imran W Ali
NPI 1235162025
$3,555.22
in general payments reported to CMS, 2019-2025
20 companies · $427 in 2025
The $427 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $838 · 2020: $165 · 2021: $1,138 · 2022: $225 · 2023: $482 · 2024: $281 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $521.26 | 2021 | |
| Janssen Pharmaceuticals, INC | $514.57 | 2019-2021 | |
| Boston Scientific Corporation | $461.55 | 2019-2025 | Eluvia, Jetstream Sc |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $410.20 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $381.48 | 2019-2025 | |
| Edwards Lifesciences Corporation | $194.28 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $188.98 | 2019-2025 | Wainua, Brilinta |
| Heartflow, INC. | $167.91 | 2025 | |
| Abbott Laboratories | $140.12 | 2019-2024 | Diamondback Peripheral, Supera, Cardiomems |
| Inari Medical, INC. | $115.72 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $102.30 | 2019-2020 | |
| Cook Medical LLC | $82.25 | 2019-2022 | |
| Lantheus Medical Imaging, INC. | $69.77 | 2022-2025 | |
| Siemens Medical Solutions USA, INC. | $67.62 | 2021 | |
| Amgen INC. | $42.87 | 2023 | Repatha |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.59 | 2023 | Jardiance |
| Becton, Dickinson and Company | $19.87 | 2024 | Powerglide |
| Bard Peripheral Vascular, INC. | $17.05 | 2025 | Wavelinq |
| Lexicon Pharmaceuticals, INC. | $15.42 | 2023 | Inpefa |
| Cardinal Health 200 LLC | $14.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.